HealthTree AML Community - HealthTree for AML

search

Sign In / Join

search

close

person Sign In / Create Account

Get connected with cutting edge treatments from specialists

Clinical trials should be considered at every stage of AML treatment. Clinical trials can provide earlier access to treatments you otherwise could not receive. Remember, today's treatments are yesterday's clinical trials.

Breaking Headlines

Oct. 04, 2022

AML Round Table: What's Next if You Relapse?

Sep. 27, 2022

AML Round Table: Mid-Year Updates in AML

Sep. 26, 2022

PedAL Dare To Dream Project For Childhood AML

Sep. 14, 2022

Partial Trial Hold Is Lifted For Take Aim Leukemia Study

Sep. 10, 2022

No Bake, High Calorie Energy Bites

Sep. 06, 2022

Blood Lines – Poetry to Celebrate Blood Cancer Awareness Month

Sep. 02, 2022

Transportation Assistance for AML Patients in the Tri-State Area

Aug. 31, 2022

Join our Adult AML Community Chapter

Aug. 29, 2022

Inflation Reduction Act: A Battle Long & Hard Fought for Patient Cost-Savings

Aug. 26, 2022

HealthTree Moves for Blood Cancer Awareness Starts September 1st!

Aug. 24, 2022

Managing Mouth Sores

Aug. 22, 2022

Early Work on ABL602: A Bispecific Antibody That Targets CLL-1 To Eliminate AML Stem Cells

Recent Articles

Childhood AML

PedAL Dare To Dream Project For Childhood AML image

PedAL Dare To Dream Project For Childhood AML

Understanding the Newly Discovered UBTF Mutation in Childhood AML image

Understanding the Newly Discovered UBTF Mutation in Childhood AML

ASH 2021: Minimizing Cardiac Toxicity in Children with Acute Myeloid Leukemia image

ASH 2021: Minimizing Cardiac Toxicity in Children with Acute Myeloid Leukemia

Targeted Therapy Using Genome Mapping for Childhood AML and Other Pediatric Cancers image

Targeted Therapy Using Genome Mapping for Childhood AML and Other Pediatric Cancers

Vyxeos Now FDA Approved for Children With Secondary AML image

Vyxeos Now FDA Approved for Children With Secondary AML

New Study Finds Higher Likelihood of AML in Children With Down Syndrome image

New Study Finds Higher Likelihood of AML in Children With Down Syndrome

New in AML

COVID Vaccines, Boosting and Evusheld in AML Patients image

COVID Vaccines, Boosting and Evusheld in AML Patients

New Drug Combo FDA Approved: Tibsovo (Ivosidenib) and Azacitidine image

New Drug Combo FDA Approved: Tibsovo (Ivosidenib) and Azacitidine

Understanding The IDH1 And IDH2 Mutations image

Understanding The IDH1 And IDH2 Mutations

Active for AML: 30 Day Activity Challenge During the Month of April image

Active for AML: 30 Day Activity Challenge During the Month of April

Progress on OmnImmune, an Allogeneic CAR-T Cell Therapy for AML image

Progress on OmnImmune, an Allogeneic CAR-T Cell Therapy for AML

Medicare Will Now Cover Free At-Home COVID-19 Tests for Beneficiaries image

Medicare Will Now Cover Free At-Home COVID-19 Tests for Beneficiaries

Life With AML

No Bake, High Calorie Energy Bites image

No Bake, High Calorie Energy Bites

Blood Lines – Poetry to Celebrate Blood Cancer Awareness Month image

Blood Lines – Poetry to Celebrate Blood Cancer Awareness Month

Transportation Assistance for AML Patients in the Tri-State Area image

Transportation Assistance for AML Patients in the Tri-State Area

Join our Adult AML Community Chapter image

Join our Adult AML Community Chapter

Inflation Reduction Act: A Battle Long & Hard Fought for Patient Cost-Savings image

Inflation Reduction Act: A Battle Long & Hard Fought for Patient Cost-Savings

HealthTree Moves for Blood Cancer Awareness Starts September 1st! image

HealthTree Moves for Blood Cancer Awareness Starts September 1st!

HealthTree

articles for HealthTree

AML Round Table: What's Next if You Relapse? AML Round Table: Mid-Year Updates in AML Podcast: Digging Deeper Into the TP53 Mutation in AML with Dr. Rory Shallis, Yale New Haven

Clinical Trials

articles for Clinical Trials

Partial Trial Hold Is Lifted For Take Aim Leukemia Study Early Work on ABL602: A Bispecific Antibody That Targets CLL-1 To Eliminate AML Stem Cells New AML CAR-T Therapy in the Works: CD70 and Azacitidine

HealthTree Press

articles for HealthTree Press

HealthTree Foundation Launches New Journaling Feature for Acute Myeloid Leukemia Patients The HealthTree® Foundation Unveils the First and Only Clinical Trial Finder Tool Designed Specifically for Acute Myeloid Leukemia (AML) Patients HealthTree Foundation wants to ease, demystify the clinical trial process for AML patients

Thanks to our HealthTree Community for AML Sponsors:

Jazz Pharmaceuticals

AbbVie

Amgen

Bristol Myers Squibb

Follow Us

instagram

youtube

Apps & Programs

Side Effect Solutions My Journal University Connect Moves

All News

All News New in AML Life With AML Childhood AML Clinical Trials HealthTree HealthTree Press

Events

All Events Life With AML Treatment & Testing Research Nutrition Fitness Financial Doctor Q&A

Round Tables

Upcoming Round Tables Past Round Tables

Podcasts

Chapters

Research

Clinical Trials

Patient Resources

AML 101 Financial Resources Find a Specialist

HealthTree Info

About HealthTree HealthTree in The News Annual Reports

Need Help?

Contact Us 1-800-709-1113

Legal Info

Terms of Use Privacy Policy

HealthTree Foundation / HealthTree for AML is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

Copyright © 2022 HealthTree Foundation. All rights reserved.

Tax ID 45-5354811